Grants & Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Grants & Projects
- 23 Finished
-
UB CAT: Development and Manufacture of a Proprietary Drug for Clinical Testing in Cancer
Hangauer, D. (PI)
03/15/16 → 06/30/16
Project: Research
-
Center for Advanced Technology in Biomedical and Bioengineering
Nowak, N. (PI), Bett, G. (CoI), Buck, M. (CoI), Buckley, M. (CoI), Canty, J. (CoI), English, K. (CoI), Hangauer, D. (CoI), Ionita, C. (CoI), Kelly, H. (CoI), Neelamegham, S. (CoI), Rittenhouse-Olson, K. (CoI), Schweser, F. (CoI), Titus, A. (CoI), Zhou, C. (CoI), Baier, R. E. (CoI), Ciancio, S. (CoI), Furlani, E. (CoI), Poulsen, D. (CoI) & Tenenbaum, S. (CoI)
NYS Department of Economic Development
07/1/15 → 06/30/16
Project: Research
-
UB CAT: Manufacturing of KX2-361 capsules, a novel therapy for the treatment of brain cancer
Hangauer, D. (PI)
07/1/14 → 06/30/15
Project: Research
-
Center for Advanced Technology in Biomedical and Bioengineering
Nowak, N. (PI), Armstrong, J. (CoI), Bett, G. (CoI), Buck, M. (CoI), Buckley, M. (CoI), Canty, J. (CoI), Fallavollita, J. (CoI), Hangauer, D. (CoI), Hostler, D. (CoI), Mollendorf, J. (CoI), Pandey, R. (CoI), Qu, J. (CoI), Ramanathan, M. (CoI), Rittenhouse-Olson, K. (CoI), Sajjad, M. (CoI), Schwartz, S. (CoI), Small, S. (CoI), Titus, A. (CoI), Baier, R. E. (CoI), Radziwon, K. (CoI), Suzuki, G. (CoI), Swartz, D. (CoI) & Tenenbaum, S. (CoI)
NYS Department of Economic Development
07/1/14 → 06/30/15
Project: Research
-
UB CAT: Development of Novel Small Molecule Immunosuppresants
Hangauer, D. (PI)
07/1/12 → 06/30/13
Project: Research
-
A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia
Kasner, M. T., Halloran, M. B., Pan, J., Ritchie, E. K., Fetterly, G. J., Kramer, D., Hangauer, D. G. & Thompson, J. E., Aug 2022, In: Investigational New Drugs. 40, 4, p. 773-781 9 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)
Smolinski, M. P., Bu, Y., Clements, J., Gelman, I. H., Hegab, T., Cutler, D. L., Fang, J. W. S., Fetterly, G., Kwan, R., Barnett, A., Lau, J. Y. N. & Hangauer, D. G., Jun 14 2018, In: Journal of Medicinal Chemistry. 61, 11, p. 4704-4719 16 p.Research output: Contribution to journal › Article › peer-review
Open Access92 Scopus citations -
KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
Ciesielski, M. J., Bu, Y., Munich, S. A., Teegarden, P., Smolinski, M. P., Clements, J. L., Lau, J. Y. N., Hangauer, D. G. & Fenstermaker, R. A., Dec 15 2018, In: Journal of Neuro-Oncology. 140, 3, p. 519-527 9 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Antitumor effect of KX-01 through inhibiting Src family kinases and mitosis
Kim, S., Min, A., Lee, K. H., Yang, Y., Kim, T. Y., Lim, J. M., Park, S. J., Nam, H. J., Kim, J. E., Song, S. H., Han, S. W., Oh, D. Y., Kim, J. H., Kim, T. Y., Hangauer, D., Lau, J. Y. N., Im, K., Lee, D. S., Bang, Y. J. & Im, S. A., Jul 1 2017, In: Cancer Research and Treatment. 49, 3, p. 643-655 13 p.Research output: Contribution to journal › Article › peer-review
Open Access27 Scopus citations -
Dual Src kinase/pretubulin inhibitor KX-01, sensitizes ERα-negative breast cancers to tamoxifen through ERα reexpression
Anbalagan, M., Sheng, M., Fleischer, B., Zhang, Y., Gao, Y., Hoang, V., Matossian, M., Burks, H. E., Burow, M. E., Collins-Burow, B. M., Hangauer, D. & Rowan, B. G., Nov 2017, In: Molecular Cancer Research. 15, 11, p. 1491-1502 12 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations